Research Studies Worldwide
For over 40 years, scientists and clinicians have studied the therapeutic efficacy of cannabis, its extracts, and refined phytochemicals. This research is accompanied by a vast amount of anecdotal evidence and case reports of therapeutic benefit.
*Source: US National Library of Medicine. Last updated June 2018.
Current State of Evidence
Chronic pain in adults
“There is substantial evidence that cannabis is an effective treatment for chronic pain in adults.”
Chemotherapy-induced nausea and vomiting
“There is conclusive evidence that oral cannabinoids are effective antiemetics in the treatment of chemotherapy‑induced nausea and vomiting.”
Muscle spasticity in multiple sclerosis (MS)
“There is substantial evidence that oral cannabinoids are an effective treatment for improving patient-reported multiple sclerosis spasticity symptoms.”
* Source: National Academies of Sciences, Engineering, and Medicine (2017) In, “The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research”
Research at Spectrum Therapeutics
Spectrum Therapeutics is a biopharmaceutical company that develops innovative cannabis-based products to create a range of effective formulations and delivery mechanisms and research their therapeutic effects.
We aim to leverage this R&D to improve the quality of life and health of those suffering from acute and chronic illnesses worldwide.
Amyotrophic Lateral Sclerosis (also known as ALS, Lou Gehrig's disease)
Anxiety and its various sub-groups (in humans and animals, in conjunction with Canopy Animal Health)
Cognitive enhancement (in humans and animals, in conjunction with Canopy Animal Health)
Pain and various sub-groups (in humans and animals, in conjunction with Canopy Animal Health)
Opioid sparing, pain management, and addiction (through Beckley Canopy Therapeutics)
Through our research programs, we aim to create natural plant-based medicines and health products derived from cannabis to improve the quality of life for those affected by acute and chronic illness. We support applicants who are rigorous with their research and committed to advancing cannabinoid science.
Due to the large number of research requests that we have received, we regret that we are not accepting new research requests at this time. Please check back with us for future research requests.